188 related articles for article (PubMed ID: 28978917)
1. Chronic sun exposure-related fusion oncogenes EGFR-PPARGC1A in cutaneous squamous cell carcinoma.
Egashira S; Jinnin M; Ajino M; Shimozono N; Okamoto S; Tasaki Y; Hirano A; Ide M; Kajihara I; Aoi J; Harada M; Igata T; Masuguchi S; Fukushima S; Ihn H
Sci Rep; 2017 Oct; 7(1):12654. PubMed ID: 28978917
[TBL] [Abstract][Full Text] [Related]
2. Proline-rich 11 (PRR11) promotes the progression of cutaneous squamous cell carcinoma by activating the EGFR signaling pathway.
Wang S; Zhang X; Lei H; Song L; Huang Y; Kang T; Zhang M; Wang N; Yang P; Feng S; Wang J; Bai R; Wang N; Wang W; Zheng Y
Mol Carcinog; 2023 May; 62(5):613-627. PubMed ID: 36727626
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNA LINC00520 prevents the progression of cutaneous squamous cell carcinoma through the inactivation of the PI3K/Akt signaling pathway by downregulating EGFR.
Mei XL; Zhong S
Chin Med J (Engl); 2019 Feb; 132(4):454-465. PubMed ID: 30707166
[TBL] [Abstract][Full Text] [Related]
4. Tumor cell-specific AIM2 regulates growth and invasion of cutaneous squamous cell carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Piipponen M; Kivisaari A; Kallajoki M; Grénman R; Peltonen J; Peltonen S; Quint KD; Bavinck JNB; Kähäri VM
Oncotarget; 2017 Jul; 8(28):45825-45836. PubMed ID: 28526809
[TBL] [Abstract][Full Text] [Related]
5. UVB induces cutaneous squamous cell carcinoma progression by de novo ID4 methylation via methylation regulating enzymes.
Li L; Li F; Xia Y; Yang X; Lv Q; Fang F; Wang Q; Bu W; Wang Y; Zhang K; Wu Y; Shen J; Jiang M
EBioMedicine; 2020 Jul; 57():102835. PubMed ID: 32574963
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-664 functions as an oncogene in cutaneous squamous cell carcinomas (cSCC) via suppressing interferon regulatory factor 2.
Li X; Zhou C; Zhang C; Xie X; Zhou Z; Zhou M; Chen L; Ding Z
J Dermatol Sci; 2019 Jun; 94(3):330-338. PubMed ID: 31138473
[TBL] [Abstract][Full Text] [Related]
7. Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy.
Uribe P; Gonzalez S
Pathol Res Pract; 2011 Jun; 207(6):337-42. PubMed ID: 21531084
[TBL] [Abstract][Full Text] [Related]
8. UV-type specific alteration of miRNA expression and its association with tumor progression and metastasis in SCC cell lines.
Chen IP; Bender M; Spassova I; Henning S; Kubat L; Fan K; Degenhardt S; Mhamdi-Ghodbani M; Sriram A; Volkmer B; Boukamp P; Becker JC; Greinert R
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3215-3231. PubMed ID: 32865618
[TBL] [Abstract][Full Text] [Related]
9. EphB2 Promotes Progression of Cutaneous Squamous Cell Carcinoma.
Farshchian M; Nissinen L; Siljamäki E; Riihilä P; Toriseva M; Kivisaari A; Ala-Aho R; Kallajoki M; Veräjänkorva E; Honkanen HK; Heljasvaara R; Pihlajaniemi T; Grénman R; Peltonen J; Peltonen S; Kähäri VM
J Invest Dermatol; 2015 Jul; 135(7):1882-1892. PubMed ID: 25789706
[TBL] [Abstract][Full Text] [Related]
10. An Ex Vivo Human Tumor Assay Shows Distinct Patterns of EGFR Trafficking in Squamous Cell Carcinoma Correlating to Therapeutic Outcomes.
Joseph SR; Gaffney D; Barry R; Hu L; Banushi B; Wells JW; Lambie D; Strutton G; Porceddu SV; Burmeister B; Leggatt GR; Schaider H; Dolcetti R; Frazer IH; Saunders NA; Foote M; Soyer HP; Simpson F
J Invest Dermatol; 2019 Jan; 139(1):213-223. PubMed ID: 30077724
[TBL] [Abstract][Full Text] [Related]
11. Bromodomain protein BRD4 promotes cell proliferation in skin squamous cell carcinoma.
Xiang T; Bai JY; She C; Yu DJ; Zhou XZ; Zhao TL
Cell Signal; 2018 Jan; 42():106-113. PubMed ID: 29050985
[TBL] [Abstract][Full Text] [Related]
12. LPCAT1 Promotes Cutaneous Squamous Cell Carcinoma via EGFR-Mediated Protein Kinase B/p38MAPK Signaling Pathways.
Huang Y; Wang Y; Wang Y; Wang N; Duan Q; Wang S; Liu M; Bilal MA; Zheng Y
J Invest Dermatol; 2022 Feb; 142(2):303-313.e9. PubMed ID: 34358528
[TBL] [Abstract][Full Text] [Related]
13. Complement C3a promotes proliferation, migration and stemness in cutaneous squamous cell carcinoma.
Fan Z; Qin J; Wang D; Geng S
J Cell Mol Med; 2019 May; 23(5):3097-3107. PubMed ID: 30825266
[TBL] [Abstract][Full Text] [Related]
14. Fibulin-3 Has Anti-Tumorigenic Activities in Cutaneous Squamous Cell Carcinoma.
Wang X; Zhang Q; Li C; Qu X; Yang P; Jia J; Song L; Fan W; Jing H; Zheng Y
J Invest Dermatol; 2019 Aug; 139(8):1798-1808.e5. PubMed ID: 30738056
[TBL] [Abstract][Full Text] [Related]
15. Long Noncoding RNA PICSAR Promotes Growth of Cutaneous Squamous Cell Carcinoma by Regulating ERK1/2 Activity.
Piipponen M; Nissinen L; Farshchian M; Riihilä P; Kivisaari A; Kallajoki M; Peltonen J; Peltonen S; Kähäri VM
J Invest Dermatol; 2016 Aug; 136(8):1701-1710. PubMed ID: 27049681
[TBL] [Abstract][Full Text] [Related]
16. New perspectives on role of tumor microenvironment in progression of cutaneous squamous cell carcinoma.
Nissinen L; Farshchian M; Riihilä P; Kähäri VM
Cell Tissue Res; 2016 Sep; 365(3):691-702. PubMed ID: 27411692
[TBL] [Abstract][Full Text] [Related]
17. MALAT1-KTN1-EGFR regulatory axis promotes the development of cutaneous squamous cell carcinoma.
Zhang Y; Gao L; Ma S; Ma J; Wang Y; Li S; Hu X; Han S; Zhou M; Zhou L; Ding Z
Cell Death Differ; 2019 Oct; 26(10):2061-2073. PubMed ID: 30683916
[TBL] [Abstract][Full Text] [Related]
18. Plexin-B1 and semaphorin 4D cooperate to promote cutaneous squamous cell carcinoma cell proliferation, migration and invasion.
Cao J; Zhang C; Chen T; Tian R; Sun S; Yu X; Xiao C; Wang G; Liu Y; Fu M; Li W
J Dermatol Sci; 2015 Aug; 79(2):127-36. PubMed ID: 26051877
[TBL] [Abstract][Full Text] [Related]
19. Vandetanib inhibits cell growth in EGFR-expressing cutaneous squamous cell carcinoma.
Kitamura S; Maeda T; Yanagi T
Biochem Biophys Res Commun; 2020 Oct; 531(3):396-401. PubMed ID: 32800552
[TBL] [Abstract][Full Text] [Related]
20. FGFR3-TACC3 fusion proteins act as naturally occurring drivers of tumor resistance by functionally substituting for EGFR/ERK signaling.
Daly C; Castanaro C; Zhang W; Zhang Q; Wei Y; Ni M; Young TM; Zhang L; Burova E; Thurston G
Oncogene; 2017 Jan; 36(4):471-481. PubMed ID: 27345413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]